Thank you for your interest in partnering with Syantra.

Become part of our mission to make early cancer detection part of routine healthcare. Partnering with Syantra puts you at the forefront of a revolution in cancer detection and treatment as you will be part of connecting the world to our revolutionary patent-pending Onco-ID™.

Onco-ID enables the earliest possible detection of cancer and empowers oncologists and pharmaceutical scientists to create personalized, precision treatments for cancer.

Learn more about our science

We are on the cusp of the next wave in both cancer detection and treatment: the time to be aligned with Syantra is NOW. Clinical studies, collaborations, license agreements, investors: we would love to hear from you, and we look forward to connecting and sharing what we have in store for the future of cancer research, detection, and treatment.

Please contact us for more information about partnering with Syantra.

Awards

Even it its earliest stages, Syantra is enjoying recognition from peers in the healthcare, technology, and social arenas, including:

  • Project Achievement Award, Association of Professional Engineers and Geoscientists of Alberta (APEGA), March 2024 (for our platform)

  • Leader of the year Award to Dr. Tina Rinker (co-founder), Start Alberta, October 2023

  • Technology Innovation Award, BioAlberta, September 2023 (for our platform)

  • International Award to Dr. Tina Rinker(co-founder), City of Calgary, June 2023

  • Research Impact Award, Schulich School of Engineering, University of Calgary 2023

  • One to Watch Award, presented to Syantra Inc. by the A100 at the Start Alberta Tech Awards, 2021

Dr. Tina Rinker accepting the 2023 Tech Awards Leader of the Year, showcasing Syantra's recognition for innovation in healthcare and technology.

Current key partners

Alberta Innovates logo, highlighting their partnership with Syantra in advancing innovative solutions for early cancer detection.
Calian logo, representing their collaboration with Syantra to support advancements in early cancer detection technology.
LifeLabs logo, highlighting their collaboration with Syantra to enhance early cancer detection through innovative diagnostics.
NHS Manchester University logo, representing their partnership with Syantra to advance early cancer detection and innovative diagnostics.
University of Calgary logo, highlighting their partnership with Syantra in advancing research and innovation in early cancer detection.
Yonsei University logo, showcasing their collaboration with Syantra to advance global research in early cancer detection and innovative diagnostics.

Announcements & stories

News about Syantra and its revolutionary approach to cancer screening.

Announcements
January 14, 2025

Syantra, Inc. Welcomes STEM Advocate and Breast Cancer Conqueror Holly Smithson to Its Board of Directors

The addition to the board comes at a crucial time as Syantra focuses on commercialization of its patent-pending early cancer detection platform, Onco-ID
Read more
Announcements
October 30, 2024

Syantra completes patent filing for "new paradigm" in early cancer detection

The patent application addresses a pioneering method for detecting cancer signals in blood and includes associated methods of intervention.
Read more
Announcements
September 11, 2024

Syantra Secures $4.9 Million in Series A-1 Funding; Adds Dr. Rick Mangat to Board of Directors

Syantra, Inc. secures new funding for expansion and commercialization of its pioneering platform for early detection of cancer
Read more
Announcements
August 27, 2024

UCalgary biomedical engineering project receives funding for joint breast cancer detection research

U.S. government grant supports international research partnership with Cornell University
Read more
View all